Related Experiment Video

Updated: Mar 19, 2026

Microdissection of Primary Renal Tissue Segments and Incorporation with Novel Scaffold-free Construct Technology
09:00

Microdissection of Primary Renal Tissue Segments and Incorporation with Novel Scaffold-free Construct Technology

Published on: March 27, 2018

8.0K

Comparison of stem cell therapies for acute kidney injury

Carol J Barnes1, Casey T Distaso1, Kristin M Spitz1

  • 1Georgetown University School of Medicine Washington, DC, USA.

American Journal of Stem Cells
|June 24, 2016
PubMed

Insights

Mesenchymal stem cells (MSCs) show promise for treating acute kidney injury (AKI). These cells offer renoprotective effects, making them a potential therapeutic option for kidney disease.

Area of Science:

  • Nephrology
  • Regenerative Medicine
  • Stem Cell Biology

Background:

  • Acute kidney injury (AKI) is a critical condition with high mortality and morbidity.
  • Stem cell therapy is a potential treatment for kidney injury, but various stem cell types are under investigation.
  • Current research lacks direct comparisons between different stem cell therapies for AKI.

Purpose of the Study:

  • To evaluate the therapeutic potential of mesenchymal stem cells (MSCs) for acute kidney injury (AKI).
  • To review the mechanisms by which MSCs exert renoprotective effects.
  • To compare the current status of MSCs with other stem cell types like induced pluripotent stem cells (iPSCs) and spermatogonial stem cells (SSCs) in AKI research.

Main Methods:

  • Review of preclinical and clinical research on stem cell therapies for AKI.
  • Analysis of the biological mechanisms of MSCs, including their secreted factors.
  • Comparison of MSCs with iPSCs and SSCs based on existing literature.

Main Results:

  • Mesenchymal stem cells (MSCs) have demonstrated significant renoprotective effects in preclinical studies.
  • MSCs promote kidney repair through the secretion of promitotic, anti-apoptotic, anti-inflammatory, and immunomodulatory factors.
  • MSCs have successfully completed Phase I clinical trials for AKI, indicating safety and potential efficacy.

Conclusions:

  • Mesenchymal stem cells (MSCs) represent a promising therapeutic strategy for acute kidney injury (AKI).
  • The multifaceted mechanisms of MSCs, including paracrine signaling, support their potential in treating kidney disease.
  • Further clinical research is warranted to fully establish MSCs as a standard treatment for AKI.
Keywords:
AKIInduced pluripotent stem cellsacute kidney injurymesenchymal stem cellsspermatogonial stem cellstreatment

More Related Videos

Evaluation of Stem Cell Therapies in a Bilateral Patellar Tendon Injury Model in Rats09:31

Evaluation of Stem Cell Therapies in a Bilateral Patellar Tendon Injury Model in Rats

Published on: March 30, 2018

11.8K
A Novel Clinical Grade Isolation Method for Human Kidney Perivascular Stromal Cells09:05

A Novel Clinical Grade Isolation Method for Human Kidney Perivascular Stromal Cells

Published on: August 7, 2017

7.4K

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.8K
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
450
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
455
Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
1.7K
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
1.1K
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
666